Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Atlas of Blood Cancer Genomes
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare cancer characterized by an indolent course; yet, some patients experience recurrence or transformation to aggressive T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL). We analyzed 178 NLPHL and 22 THRLBCL cases using whole transcriptome RNA sequencing to elucidate clinical, histological, and molecular characteristics. NLPHL patients were younger with favorable outcomes, whereas THRLBCL patients presented at an older age with advanced-stage disease and worse prognosis. Variant immuno-architectural patterns (IAPs) in NLPHL exhibited transcriptional profiles that overlapped with THRLBCL, especially in cases with splenic involvement and high Lymphocyte-Predominant International Prognostic Scores (LPIPS). Tumor microenvironment (TME) deconvolution revealed that classical NLPHL is rich in B cells, variant NLPHL exhibits intermediate profiles, and THRLBCL is characterized by increased infiltration of activated CD4+ and CD8+ T cells and macrophages. Notably, high LP-IPS combined with elevated follicular T-helper cell abundance was associated with worse clinical outcomes in NLPHL patients. Strong B-cell and helper T-cell signatures characterized NLPHLs, while THRLBCL was enriched for macrophage, monocyte-mediated, and cytotoxic T-cell pathways. Additionally, THRLBCLs exhibited elevated expression of immune checkpoint-related genes, suggesting an immunosuppressive TME. Top-scoring pair analysis validated a progressive transcriptional continuum from classical NLPHL to variant NLPHL, culminating in THRLBCL. These findings underscore the significance of TME composition and immune checkpoint gene expression in the pathobiology and clinical course of NLPHL and THRLBCL, offering potential avenues for targeted immunotherapeutic strategies.
- Type: Cancer Genomics
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000001928 | Illumina NovaSeq X | 200 |
